Filing Details

Accession Number:
0001493152-21-009359
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-21 15:18:39
Reporting Period:
2021-04-20
Accepted Time:
2021-04-21 15:18:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1460702 Qualigen Therapeutics Inc. QLGN Pharmaceutical Preparations (2834) 263474527
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1812504 S. Michael Poirier C/O Qualigen Therapeutics, Inc.,
2042 Corte Del Nogal
Carlsbad CA 92011
Chairman, Ceo & President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-20 11,005 $1.80 11,005 No 4 P Indirect By IRA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By IRA
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 169,202 Direct